Clinical trial
Phase IV STudy of Tacrobell in Active Rheumatoid Arthritis
NCT01746680 is registered in ClinicalTrials.gov with Chong Kun Dang Pharmaceutical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV STudy of Tacrobell in Active Rheumatoid Arthritis
- Lead sponsor
- Chong Kun Dang Pharmaceutical
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- June 30, 2015
- Enrollment
- 111 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis